Peña-Hernández, Mario A.
Alfajaro, Mia Madel
Filler, Renata B.
Moriyama, Miyu https://orcid.org/0000-0003-0310-9047
Keeler, Emma L.
Ranglin, Zara E. https://orcid.org/0009-0005-0479-7728
Kong, Yong https://orcid.org/0000-0002-2881-5274
Mao, Tianyang https://orcid.org/0000-0001-9251-8592
Menasche, Bridget L. https://orcid.org/0000-0003-3520-2422
Mankowski, Madeleine C. https://orcid.org/0000-0002-8640-174X
Zhao, Zhe https://orcid.org/0000-0002-4119-0504
Vogels, Chantal B. F. https://orcid.org/0000-0003-0027-6480
Hahn, Anne M. https://orcid.org/0000-0003-0710-6775
Kalinich, Chaney C. https://orcid.org/0000-0001-9675-0065
Zhang, Shuo
Huston, Nicholas
Wan, Han
Araujo-Tavares, Rafael https://orcid.org/0000-0003-0278-1528
Lindenbach, Brett D.
Homer, Robert
Pyle, Anna Marie https://orcid.org/0000-0001-9045-8872
Martinez, David R.
Grubaugh, Nathan D. https://orcid.org/0000-0003-2031-1933
Israelow, Benjamin https://orcid.org/0000-0002-1308-8246
Iwasaki, Akiko https://orcid.org/0000-0002-7824-9856
Wilen, Craig B. https://orcid.org/0000-0003-2495-9403
Funding for this research was provided by:
Burroughs Wellcome Fund
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (5T32HL007974)
Article History
Received: 17 April 2023
Accepted: 19 June 2024
First Online: 29 July 2024
Competing interests
: A.I. serves as a consultant for RIGImmune, Xanadu Bio, Paratus Bio and Invisishield, and serves on the Board of Directors for Roche Holdings Ltd. A.I. is an investigator of the Howard Hughes Medical Institute. C.B.W. is on the Scientific Advisory Board for ExcepGen. The remaining authors declare no competing interests.